Literature DB >> 15006150

A sensitive, robust high-throughput electrochemiluminescence assay for rat insulin.

Rajasree Golla1, Ramakrishna Seethala.   

Abstract

In diabetes research, mouse and rat models are used for in vivo experiments, and quantification of insulin in serum samples under different pathophysiological conditions and after treatment with compounds is essential. There are few commercial radioimmunoassay and enzyme-linked immunosorbent assay (ELISA) assay kits to determine the rat/mouse plasma levels of insulin. However, reliability in insulin measurements using the available biological assays is a great concern. The authors report a robust, extremely sensitive electrochemiluminescence (ECL) insulin assay using the Origen technology platform. The assay performance, as judged by the Z' value of 0.82+/-0.03 and the signal-to-background (S/B) ratio of 133, suggests that this is a robust and reliable assay. The intra-assay and interassay variation is less than 5%. The dynamic range of detection for insulin is 5 pg to 5 ng in the ECL assays. Recovery of insulin was about 100% when different volumes of serum were spiked with exogenous insulin. These results suggest that the ECL insulin assay is an extremely sensitive, robust, nonradioactive homogeneous assay and can be used successfully to determine the insulin levels in rodent serum samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15006150     DOI: 10.1177/1087057103260515

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  3 in total

1.  The use of AlphaScreen technology in HTS: current status.

Authors:  Richard M Eglen; Terry Reisine; Philippe Roby; Nathalie Rouleau; Chantal Illy; Roger Bossé; Martina Bielefeld
Journal:  Curr Chem Genomics       Date:  2008-02-25

2.  Differentiation of fetal pancreatic stem cells into neuron-like and islet-like cells in vitro.

Authors:  Xiufeng Hua; Yanwei Wang; Peiwen Lian; Shouxin Zhang; Jianyuan Li; Haiyan Wang; Shulin Chen; Wei Gao
Journal:  Neural Regen Res       Date:  2012-03-05       Impact factor: 5.135

3.  HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening.

Authors:  Kemperly Dynon; Sophea Heng; Michelle Puryer; Ying Li; Kelly Walton; Yaeta Endo; Guiying Nie
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.